Department of Surgery, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Fischell Department of Bioengineering, A. James Clark School of Engineering, University of Maryland, College Park, Maryland, USA.
Artif Organs. 2024 May;48(5):514-524. doi: 10.1111/aor.14698. Epub 2023 Dec 19.
von Willebrand factor (vWF) plays a crucial role in physiological hemostasis through platelet and subendothelial collagen adhesion. However, its role in shear-induced platelet activation and functional alteration under non-physiological conditions common to blood-contacting medical devices (BCMDs) is not well investigated.
Fresh healthy human blood was treated with an anti-vWF antibody to block vWF-GPIbα interaction. Untreated blood was used as a control. They were exposed to three levels of non-physiological shear stress (NPSS) (75, 125, and 175 Pa) through a shearing device with an exposure time of 0.5 s to mimic typical shear conditions in BCMDs. Flow cytometric assays were used to measure the expression levels of PAC-1 and P-Selectin and platelet aggregates for platelet activation and the expression levels of GPIbα, GPIIb/IIIa, and GPVI for receptor shedding. Collagen/ristocetin-induced platelet aggregation capacity was characterized by aggregometry.
The levels of platelet activation and aggregates increased with increasing NPSS in the untreated blood. More receptors were lost with increasing NPSS, resulting in a decreased capacity of collagen/ristocetin-induced platelet aggregation. In contrast, the increase in platelet activation and aggregates after exposure to NPSS, even at the highest level of NPSS, was significantly lower in treated blood. Nevertheless, there was no notable difference in receptor shedding, especially for GPIIb/IIIa and GPVI, between the two blood groups at the same level of NPSS. The block of vWF exacerbated the decreased capacity of collagen/ristocetin-induced platelet aggregation.
High NPSS activates platelets mainly by enhancing the vWF-GPIbα interaction. Platelet activation and receptor shedding induced by high NPSS likely occur through different pathways.
血管性血友病因子(vWF)通过血小板与内皮下胶原的黏附,在生理性止血中发挥关键作用。然而,其在非生理剪切力(NPSS)下与接触血液的医疗器械(BCMD)中常见的血小板激活和功能改变中的作用尚未得到充分研究。
用抗 vWF 抗体处理新鲜健康人血以阻断 vWF-GPIbα 相互作用。未处理的血液作为对照。通过一个剪切装置使它们暴露于三个水平的 NPSS(75、125 和 175Pa),暴露时间为 0.5s,以模拟 BCMD 中典型的剪切条件。流式细胞术检测血小板激活的 PAC-1 和 P-选择素表达水平和血小板聚集,以及受体脱落的 GPIbα、GPIIb/IIIa 和 GPVI 表达水平。通过聚集仪来评估胶原/瑞斯托菌素诱导的血小板聚集能力。
在未处理的血液中,随着 NPSS 的增加,血小板激活和聚集水平增加。随着 NPSS 的增加,更多的受体丢失,导致胶原/瑞斯托菌素诱导的血小板聚集能力下降。相比之下,在暴露于 NPSS 后,即使在最高水平的 NPSS 下,处理过的血液中血小板激活和聚集的增加也显著降低。然而,在相同 NPSS 水平下,两种血液之间的受体脱落,尤其是 GPIIb/IIIa 和 GPVI,没有明显差异。vWF 的阻断加剧了胶原/瑞斯托菌素诱导的血小板聚集能力的降低。
高 NPSS 主要通过增强 vWF-GPIbα 相互作用来激活血小板。高 NPSS 诱导的血小板激活和受体脱落可能通过不同的途径发生。